Ibrutinib treatment leads to H3K27ac redistribution in chronic lymphocytic leukemia

Adam Lambe; Nicolai K. H. Barth; Nikos Papakonstantinou; Charalampos Xanthopoulos; Maria Gounari; Kostas Stamatopoulos; Leila Taher; Efterpi Kostareli

Ibrutinib treatment leads to H3K27ac redistribution in chronic lymphocytic leukemia

Adam Lambe, Nicolai K. H. Barth, Nikos Papakonstantinou, Charalampos Xanthopoulos, Maria Gounari, Kostas Stamatopoulos, Leila Taher, Efterpi Kostareli

Institut für Biomedical Informatics (7200)

Publikation: Beitrag in einer Fachzeitschrift › Abstract › Begutachtung

Originalsprache	englisch
Seiten (von - bis)	252-253
Fachzeitschrift	Leukemia & Lymphoma
Jahrgang	61
Ausgabenummer	Supp.1
Publikationsstatus	Veröffentlicht - 16 März 2020

Dieses zitieren

@article{6fa351c8e3b64a098fd69315966f4dda,

title = "Ibrutinib treatment leads to H3K27ac redistribution in chronic lymphocytic leukemia",

author = "Adam Lambe and Barth, {Nicolai K. H.} and Nikos Papakonstantinou and Charalampos Xanthopoulos and Maria Gounari and Kostas Stamatopoulos and Leila Taher and Efterpi Kostareli",

year = "2020",

month = mar,

day = "16",

language = "English",

volume = "61",

pages = "252--253",

journal = "Leukemia & Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis Group",

number = "Supp.1",

}

TY - JOUR

T1 - Ibrutinib treatment leads to H3K27ac redistribution in chronic lymphocytic leukemia

AU - Lambe, Adam

AU - Barth, Nicolai K. H.

AU - Papakonstantinou, Nikos

AU - Xanthopoulos, Charalampos

AU - Gounari, Maria

AU - Stamatopoulos, Kostas

AU - Taher, Leila

AU - Kostareli, Efterpi

PY - 2020/3/16

Y1 - 2020/3/16

M3 - Abstract

SN - 1042-8194

VL - 61

SP - 252

EP - 253

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - Supp.1

ER -